nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Raloxifene—osteoporosis	0.0857	0.177	CbGbCtD
Tramadol—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0827	0.171	CbGbCtD
Tramadol—CYP2B6—Cholecalciferol—osteoporosis	0.0661	0.137	CbGbCtD
Tramadol—CYP3A4—Estropipate—osteoporosis	0.0394	0.0815	CbGbCtD
Tramadol—CYP3A4—Calcitriol—osteoporosis	0.0394	0.0815	CbGbCtD
Tramadol—CYP2D6—Cholecalciferol—osteoporosis	0.0319	0.066	CbGbCtD
Tramadol—CYP3A4—Ergocalciferol—osteoporosis	0.0315	0.0651	CbGbCtD
Tramadol—CYP3A4—Raloxifene—osteoporosis	0.0263	0.0544	CbGbCtD
Tramadol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0254	0.0525	CbGbCtD
Tramadol—CYP3A4—Cholecalciferol—osteoporosis	0.0203	0.042	CbGbCtD
Tramadol—CYP3A4—Conjugated Estrogens—osteoporosis	0.0187	0.0385	CbGbCtD
Tramadol—CYP3A4—Estradiol—osteoporosis	0.0164	0.0338	CbGbCtD
Tramadol—Convulsion—Conjugated Estrogens—osteoporosis	0.00012	0.000249	CcSEcCtD
Tramadol—Dry mouth—Zoledronate—osteoporosis	0.00012	0.000249	CcSEcCtD
Tramadol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00012	0.000248	CcSEcCtD
Tramadol—Fatigue—Ethinyl Estradiol—osteoporosis	0.00012	0.000248	CcSEcCtD
Tramadol—Pruritus—Alendronate—osteoporosis	0.00012	0.000247	CcSEcCtD
Tramadol—Dyspepsia—Risedronate—osteoporosis	0.000119	0.000247	CcSEcCtD
Tramadol—Eye disorder—Estradiol—osteoporosis	0.000119	0.000247	CcSEcCtD
Tramadol—Tinnitus—Estradiol—osteoporosis	0.000119	0.000246	CcSEcCtD
Tramadol—Constipation—Ethinyl Estradiol—osteoporosis	0.000119	0.000246	CcSEcCtD
Tramadol—Confusional state—Zoledronate—osteoporosis	0.000119	0.000246	CcSEcCtD
Tramadol—Hypersensitivity—Calcitriol—osteoporosis	0.000119	0.000246	CcSEcCtD
Tramadol—Flushing—Estradiol—osteoporosis	0.000119	0.000245	CcSEcCtD
Tramadol—Cardiac disorder—Estradiol—osteoporosis	0.000119	0.000245	CcSEcCtD
Tramadol—Chest pain—Conjugated Estrogens—osteoporosis	0.000118	0.000245	CcSEcCtD
Tramadol—Myalgia—Conjugated Estrogens—osteoporosis	0.000118	0.000245	CcSEcCtD
Tramadol—Arthralgia—Conjugated Estrogens—osteoporosis	0.000118	0.000245	CcSEcCtD
Tramadol—Asthenia—Ibandronate—osteoporosis	0.000118	0.000244	CcSEcCtD
Tramadol—Anxiety—Conjugated Estrogens—osteoporosis	0.000118	0.000244	CcSEcCtD
Tramadol—Nausea—Etidronic acid—osteoporosis	0.000118	0.000244	CcSEcCtD
Tramadol—Anaphylactic shock—Zoledronate—osteoporosis	0.000118	0.000244	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000118	0.000243	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000118	0.000243	CcSEcCtD
Tramadol—Diarrhoea—Estropipate—osteoporosis	0.000117	0.000243	CcSEcCtD
Tramadol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000117	0.000242	CcSEcCtD
Tramadol—Infection—Zoledronate—osteoporosis	0.000117	0.000242	CcSEcCtD
Tramadol—Fatigue—Risedronate—osteoporosis	0.000117	0.000242	CcSEcCtD
Tramadol—Insomnia—Pamidronate—osteoporosis	0.000117	0.000241	CcSEcCtD
Tramadol—Pruritus—Ibandronate—osteoporosis	0.000116	0.000241	CcSEcCtD
Tramadol—Pain—Risedronate—osteoporosis	0.000116	0.00024	CcSEcCtD
Tramadol—Constipation—Risedronate—osteoporosis	0.000116	0.00024	CcSEcCtD
Tramadol—Angiopathy—Estradiol—osteoporosis	0.000116	0.00024	CcSEcCtD
Tramadol—Shock—Zoledronate—osteoporosis	0.000116	0.00024	CcSEcCtD
Tramadol—Paraesthesia—Pamidronate—osteoporosis	0.000116	0.00024	CcSEcCtD
Tramadol—Diarrhoea—Alendronate—osteoporosis	0.000116	0.000239	CcSEcCtD
Tramadol—Asthenia—Calcitriol—osteoporosis	0.000116	0.000239	CcSEcCtD
Tramadol—Nervous system disorder—Zoledronate—osteoporosis	0.000116	0.000239	CcSEcCtD
Tramadol—Immune system disorder—Estradiol—osteoporosis	0.000115	0.000239	CcSEcCtD
Tramadol—Thrombocytopenia—Zoledronate—osteoporosis	0.000115	0.000239	CcSEcCtD
Tramadol—Mediastinal disorder—Estradiol—osteoporosis	0.000115	0.000238	CcSEcCtD
Tramadol—Dyspnoea—Pamidronate—osteoporosis	0.000115	0.000238	CcSEcCtD
Tramadol—Tachycardia—Zoledronate—osteoporosis	0.000115	0.000238	CcSEcCtD
Tramadol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000115	0.000237	CcSEcCtD
Tramadol—Chills—Estradiol—osteoporosis	0.000115	0.000237	CcSEcCtD
Tramadol—Somnolence—Pamidronate—osteoporosis	0.000115	0.000237	CcSEcCtD
Tramadol—Skin disorder—Zoledronate—osteoporosis	0.000114	0.000237	CcSEcCtD
Tramadol—Pruritus—Calcitriol—osteoporosis	0.000114	0.000236	CcSEcCtD
Tramadol—Hyperhidrosis—Zoledronate—osteoporosis	0.000114	0.000236	CcSEcCtD
Tramadol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000114	0.000235	CcSEcCtD
Tramadol—Diarrhoea—Raloxifene—osteoporosis	0.000114	0.000235	CcSEcCtD
Tramadol—Dyspepsia—Pamidronate—osteoporosis	0.000114	0.000235	CcSEcCtD
Tramadol—Dizziness—Estropipate—osteoporosis	0.000114	0.000235	CcSEcCtD
Tramadol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000113	0.000235	CcSEcCtD
Tramadol—Infection—Conjugated Estrogens—osteoporosis	0.000113	0.000233	CcSEcCtD
Tramadol—Diarrhoea—Ibandronate—osteoporosis	0.000113	0.000233	CcSEcCtD
Tramadol—Anorexia—Zoledronate—osteoporosis	0.000112	0.000232	CcSEcCtD
Tramadol—Decreased appetite—Pamidronate—osteoporosis	0.000112	0.000232	CcSEcCtD
Tramadol—Mental disorder—Estradiol—osteoporosis	0.000112	0.000232	CcSEcCtD
Tramadol—Dizziness—Alendronate—osteoporosis	0.000112	0.000231	CcSEcCtD
Tramadol—Shock—Conjugated Estrogens—osteoporosis	0.000112	0.000231	CcSEcCtD
Tramadol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000111	0.00023	CcSEcCtD
Tramadol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000111	0.00023	CcSEcCtD
Tramadol—Erythema—Estradiol—osteoporosis	0.000111	0.00023	CcSEcCtD
Tramadol—Malnutrition—Estradiol—osteoporosis	0.000111	0.00023	CcSEcCtD
Tramadol—Fatigue—Pamidronate—osteoporosis	0.000111	0.00023	CcSEcCtD
Tramadol—Gastrointestinal pain—Risedronate—osteoporosis	0.000111	0.000229	CcSEcCtD
Tramadol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000111	0.000229	CcSEcCtD
Tramadol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000111	0.000229	CcSEcCtD
Tramadol—Constipation—Pamidronate—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Pain—Pamidronate—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Diarrhoea—Calcitriol—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Skin disorder—Conjugated Estrogens—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Hypotension—Zoledronate—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00011	0.000228	CcSEcCtD
Tramadol—Dizziness—Raloxifene—osteoporosis	0.00011	0.000227	CcSEcCtD
Tramadol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00011	0.000227	CcSEcCtD
Tramadol—Flatulence—Estradiol—osteoporosis	0.00011	0.000227	CcSEcCtD
Tramadol—Tension—Estradiol—osteoporosis	0.000109	0.000226	CcSEcCtD
Tramadol—Vomiting—Estropipate—osteoporosis	0.000109	0.000226	CcSEcCtD
Tramadol—Dysgeusia—Estradiol—osteoporosis	0.000109	0.000225	CcSEcCtD
Tramadol—Dizziness—Ibandronate—osteoporosis	0.000109	0.000225	CcSEcCtD
Tramadol—Rash—Estropipate—osteoporosis	0.000108	0.000224	CcSEcCtD
Tramadol—Dermatitis—Estropipate—osteoporosis	0.000108	0.000224	CcSEcCtD
Tramadol—Anorexia—Conjugated Estrogens—osteoporosis	0.000108	0.000224	CcSEcCtD
Tramadol—Nervousness—Estradiol—osteoporosis	0.000108	0.000223	CcSEcCtD
Tramadol—Urticaria—Risedronate—osteoporosis	0.000108	0.000223	CcSEcCtD
Tramadol—Back pain—Estradiol—osteoporosis	0.000108	0.000223	CcSEcCtD
Tramadol—Headache—Estropipate—osteoporosis	0.000108	0.000222	CcSEcCtD
Tramadol—Vomiting—Alendronate—osteoporosis	0.000108	0.000222	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000107	0.000222	CcSEcCtD
Tramadol—Abdominal pain—Risedronate—osteoporosis	0.000107	0.000222	CcSEcCtD
Tramadol—Body temperature increased—Risedronate—osteoporosis	0.000107	0.000222	CcSEcCtD
Tramadol—Muscle spasms—Estradiol—osteoporosis	0.000107	0.000221	CcSEcCtD
Tramadol—Rash—Alendronate—osteoporosis	0.000107	0.000221	CcSEcCtD
Tramadol—Insomnia—Zoledronate—osteoporosis	0.000107	0.00022	CcSEcCtD
Tramadol—Dermatitis—Alendronate—osteoporosis	0.000107	0.00022	CcSEcCtD
Tramadol—Feeling abnormal—Pamidronate—osteoporosis	0.000106	0.00022	CcSEcCtD
Tramadol—Hypotension—Conjugated Estrogens—osteoporosis	0.000106	0.000219	CcSEcCtD
Tramadol—Headache—Alendronate—osteoporosis	0.000106	0.000219	CcSEcCtD
Tramadol—Paraesthesia—Zoledronate—osteoporosis	0.000106	0.000219	CcSEcCtD
Tramadol—Vomiting—Raloxifene—osteoporosis	0.000106	0.000219	CcSEcCtD
Tramadol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000105	0.000218	CcSEcCtD
Tramadol—Dyspnoea—Zoledronate—osteoporosis	0.000105	0.000217	CcSEcCtD
Tramadol—Rash—Raloxifene—osteoporosis	0.000105	0.000217	CcSEcCtD
Tramadol—Dermatitis—Raloxifene—osteoporosis	0.000105	0.000217	CcSEcCtD
Tramadol—Somnolence—Zoledronate—osteoporosis	0.000105	0.000217	CcSEcCtD
Tramadol—Vomiting—Ibandronate—osteoporosis	0.000105	0.000217	CcSEcCtD
Tramadol—Tremor—Estradiol—osteoporosis	0.000104	0.000216	CcSEcCtD
Tramadol—Headache—Raloxifene—osteoporosis	0.000104	0.000215	CcSEcCtD
Tramadol—Rash—Ibandronate—osteoporosis	0.000104	0.000215	CcSEcCtD
Tramadol—Dermatitis—Ibandronate—osteoporosis	0.000104	0.000215	CcSEcCtD
Tramadol—Dyspepsia—Zoledronate—osteoporosis	0.000104	0.000214	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000103	0.000214	CcSEcCtD
Tramadol—Ill-defined disorder—Estradiol—osteoporosis	0.000103	0.000213	CcSEcCtD
Tramadol—Headache—Ibandronate—osteoporosis	0.000103	0.000213	CcSEcCtD
Tramadol—Insomnia—Conjugated Estrogens—osteoporosis	0.000103	0.000212	CcSEcCtD
Tramadol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000103	0.000212	CcSEcCtD
Tramadol—Vomiting—Calcitriol—osteoporosis	0.000102	0.000212	CcSEcCtD
Tramadol—Decreased appetite—Zoledronate—osteoporosis	0.000102	0.000212	CcSEcCtD
Tramadol—Agitation—Estradiol—osteoporosis	0.000102	0.000211	CcSEcCtD
Tramadol—Nausea—Estropipate—osteoporosis	0.000102	0.000211	CcSEcCtD
Tramadol—Abdominal pain—Pamidronate—osteoporosis	0.000102	0.000211	CcSEcCtD
Tramadol—Body temperature increased—Pamidronate—osteoporosis	0.000102	0.000211	CcSEcCtD
Tramadol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000102	0.000211	CcSEcCtD
Tramadol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000102	0.00021	CcSEcCtD
Tramadol—Angioedema—Estradiol—osteoporosis	0.000102	0.00021	CcSEcCtD
Tramadol—Rash—Calcitriol—osteoporosis	0.000102	0.00021	CcSEcCtD
Tramadol—Fatigue—Zoledronate—osteoporosis	0.000102	0.00021	CcSEcCtD
Tramadol—Dermatitis—Calcitriol—osteoporosis	0.000102	0.00021	CcSEcCtD
Tramadol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000101	0.000209	CcSEcCtD
Tramadol—Headache—Calcitriol—osteoporosis	0.000101	0.000209	CcSEcCtD
Tramadol—Somnolence—Conjugated Estrogens—osteoporosis	0.000101	0.000209	CcSEcCtD
Tramadol—Pain—Zoledronate—osteoporosis	0.000101	0.000208	CcSEcCtD
Tramadol—Constipation—Zoledronate—osteoporosis	0.000101	0.000208	CcSEcCtD
Tramadol—Nausea—Alendronate—osteoporosis	0.0001	0.000208	CcSEcCtD
Tramadol—Malaise—Estradiol—osteoporosis	0.0001	0.000207	CcSEcCtD
Tramadol—Hypersensitivity—Risedronate—osteoporosis	0.0001	0.000207	CcSEcCtD
Tramadol—Vertigo—Estradiol—osteoporosis	0.0001	0.000207	CcSEcCtD
Tramadol—Dyspepsia—Conjugated Estrogens—osteoporosis	9.99e-05	0.000207	CcSEcCtD
Tramadol—Asthenia—Ethinyl Estradiol—osteoporosis	9.99e-05	0.000207	CcSEcCtD
Tramadol—Syncope—Estradiol—osteoporosis	9.98e-05	0.000206	CcSEcCtD
Tramadol—Nausea—Raloxifene—osteoporosis	9.88e-05	0.000204	CcSEcCtD
Tramadol—Decreased appetite—Conjugated Estrogens—osteoporosis	9.86e-05	0.000204	CcSEcCtD
Tramadol—Pruritus—Ethinyl Estradiol—osteoporosis	9.85e-05	0.000204	CcSEcCtD
Tramadol—Palpitations—Estradiol—osteoporosis	9.83e-05	0.000203	CcSEcCtD
Tramadol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.79e-05	0.000203	CcSEcCtD
Tramadol—Fatigue—Conjugated Estrogens—osteoporosis	9.78e-05	0.000202	CcSEcCtD
Tramadol—Nausea—Ibandronate—osteoporosis	9.78e-05	0.000202	CcSEcCtD
Tramadol—Loss of consciousness—Estradiol—osteoporosis	9.78e-05	0.000202	CcSEcCtD
Tramadol—Asthenia—Risedronate—osteoporosis	9.74e-05	0.000201	CcSEcCtD
Tramadol—Feeling abnormal—Zoledronate—osteoporosis	9.71e-05	0.000201	CcSEcCtD
Tramadol—Cough—Estradiol—osteoporosis	9.71e-05	0.000201	CcSEcCtD
Tramadol—Pain—Conjugated Estrogens—osteoporosis	9.7e-05	0.000201	CcSEcCtD
Tramadol—Constipation—Conjugated Estrogens—osteoporosis	9.7e-05	0.000201	CcSEcCtD
Tramadol—Gastrointestinal pain—Zoledronate—osteoporosis	9.63e-05	0.000199	CcSEcCtD
Tramadol—Hypertension—Estradiol—osteoporosis	9.61e-05	0.000199	CcSEcCtD
Tramadol—Pruritus—Risedronate—osteoporosis	9.6e-05	0.000199	CcSEcCtD
Tramadol—Nausea—Calcitriol—osteoporosis	9.57e-05	0.000198	CcSEcCtD
Tramadol—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.52e-05	0.000197	CcSEcCtD
Tramadol—Hypersensitivity—Pamidronate—osteoporosis	9.5e-05	0.000197	CcSEcCtD
Tramadol—Arthralgia—Estradiol—osteoporosis	9.47e-05	0.000196	CcSEcCtD
Tramadol—Myalgia—Estradiol—osteoporosis	9.47e-05	0.000196	CcSEcCtD
Tramadol—Chest pain—Estradiol—osteoporosis	9.47e-05	0.000196	CcSEcCtD
Tramadol—Anxiety—Estradiol—osteoporosis	9.44e-05	0.000195	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.41e-05	0.000195	CcSEcCtD
Tramadol—Urticaria—Zoledronate—osteoporosis	9.36e-05	0.000194	CcSEcCtD
Tramadol—Discomfort—Estradiol—osteoporosis	9.36e-05	0.000194	CcSEcCtD
Tramadol—Abdominal pain—Zoledronate—osteoporosis	9.31e-05	0.000193	CcSEcCtD
Tramadol—Body temperature increased—Zoledronate—osteoporosis	9.31e-05	0.000193	CcSEcCtD
Tramadol—Diarrhoea—Risedronate—osteoporosis	9.28e-05	0.000192	CcSEcCtD
Tramadol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.28e-05	0.000192	CcSEcCtD
Tramadol—Dry mouth—Estradiol—osteoporosis	9.26e-05	0.000192	CcSEcCtD
Tramadol—Asthenia—Pamidronate—osteoporosis	9.25e-05	0.000191	CcSEcCtD
Tramadol—Dizziness—Ethinyl Estradiol—osteoporosis	9.2e-05	0.00019	CcSEcCtD
Tramadol—Confusional state—Estradiol—osteoporosis	9.16e-05	0.000189	CcSEcCtD
Tramadol—Pruritus—Pamidronate—osteoporosis	9.13e-05	0.000189	CcSEcCtD
Tramadol—Anaphylactic shock—Estradiol—osteoporosis	9.08e-05	0.000188	CcSEcCtD
Tramadol—Infection—Estradiol—osteoporosis	9.02e-05	0.000187	CcSEcCtD
Tramadol—Urticaria—Conjugated Estrogens—osteoporosis	9.01e-05	0.000186	CcSEcCtD
Tramadol—Dizziness—Risedronate—osteoporosis	8.97e-05	0.000186	CcSEcCtD
Tramadol—Abdominal pain—Conjugated Estrogens—osteoporosis	8.97e-05	0.000185	CcSEcCtD
Tramadol—Body temperature increased—Conjugated Estrogens—osteoporosis	8.97e-05	0.000185	CcSEcCtD
Tramadol—Shock—Estradiol—osteoporosis	8.93e-05	0.000185	CcSEcCtD
Tramadol—Nervous system disorder—Estradiol—osteoporosis	8.9e-05	0.000184	CcSEcCtD
Tramadol—Tachycardia—Estradiol—osteoporosis	8.86e-05	0.000183	CcSEcCtD
Tramadol—Vomiting—Ethinyl Estradiol—osteoporosis	8.85e-05	0.000183	CcSEcCtD
Tramadol—Diarrhoea—Pamidronate—osteoporosis	8.83e-05	0.000183	CcSEcCtD
Tramadol—Skin disorder—Estradiol—osteoporosis	8.82e-05	0.000182	CcSEcCtD
Tramadol—Hyperhidrosis—Estradiol—osteoporosis	8.78e-05	0.000182	CcSEcCtD
Tramadol—Rash—Ethinyl Estradiol—osteoporosis	8.78e-05	0.000181	CcSEcCtD
Tramadol—Dermatitis—Ethinyl Estradiol—osteoporosis	8.77e-05	0.000181	CcSEcCtD
Tramadol—Headache—Ethinyl Estradiol—osteoporosis	8.72e-05	0.00018	CcSEcCtD
Tramadol—Hypersensitivity—Zoledronate—osteoporosis	8.68e-05	0.00018	CcSEcCtD
Tramadol—Vomiting—Risedronate—osteoporosis	8.63e-05	0.000178	CcSEcCtD
Tramadol—Rash—Risedronate—osteoporosis	8.56e-05	0.000177	CcSEcCtD
Tramadol—Dermatitis—Risedronate—osteoporosis	8.55e-05	0.000177	CcSEcCtD
Tramadol—Dizziness—Pamidronate—osteoporosis	8.53e-05	0.000176	CcSEcCtD
Tramadol—Headache—Risedronate—osteoporosis	8.5e-05	0.000176	CcSEcCtD
Tramadol—Asthenia—Zoledronate—osteoporosis	8.45e-05	0.000175	CcSEcCtD
Tramadol—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.36e-05	0.000173	CcSEcCtD
Tramadol—Pruritus—Zoledronate—osteoporosis	8.34e-05	0.000172	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Estradiol—osteoporosis	8.27e-05	0.000171	CcSEcCtD
Tramadol—Nausea—Ethinyl Estradiol—osteoporosis	8.27e-05	0.000171	CcSEcCtD
Tramadol—Insomnia—Estradiol—osteoporosis	8.21e-05	0.00017	CcSEcCtD
Tramadol—Vomiting—Pamidronate—osteoporosis	8.2e-05	0.00017	CcSEcCtD
Tramadol—Paraesthesia—Estradiol—osteoporosis	8.15e-05	0.000169	CcSEcCtD
Tramadol—Asthenia—Conjugated Estrogens—osteoporosis	8.14e-05	0.000168	CcSEcCtD
Tramadol—Rash—Pamidronate—osteoporosis	8.13e-05	0.000168	CcSEcCtD
Tramadol—Dermatitis—Pamidronate—osteoporosis	8.13e-05	0.000168	CcSEcCtD
Tramadol—Dyspnoea—Estradiol—osteoporosis	8.1e-05	0.000167	CcSEcCtD
Tramadol—Headache—Pamidronate—osteoporosis	8.08e-05	0.000167	CcSEcCtD
Tramadol—Somnolence—Estradiol—osteoporosis	8.07e-05	0.000167	CcSEcCtD
Tramadol—Diarrhoea—Zoledronate—osteoporosis	8.06e-05	0.000167	CcSEcCtD
Tramadol—Nausea—Risedronate—osteoporosis	8.06e-05	0.000167	CcSEcCtD
Tramadol—Pruritus—Conjugated Estrogens—osteoporosis	8.03e-05	0.000166	CcSEcCtD
Tramadol—Dyspepsia—Estradiol—osteoporosis	7.99e-05	0.000165	CcSEcCtD
Tramadol—Decreased appetite—Estradiol—osteoporosis	7.89e-05	0.000163	CcSEcCtD
Tramadol—Gastrointestinal disorder—Estradiol—osteoporosis	7.84e-05	0.000162	CcSEcCtD
Tramadol—Fatigue—Estradiol—osteoporosis	7.83e-05	0.000162	CcSEcCtD
Tramadol—Dizziness—Zoledronate—osteoporosis	7.79e-05	0.000161	CcSEcCtD
Tramadol—Constipation—Estradiol—osteoporosis	7.76e-05	0.000161	CcSEcCtD
Tramadol—Pain—Estradiol—osteoporosis	7.76e-05	0.000161	CcSEcCtD
Tramadol—Diarrhoea—Conjugated Estrogens—osteoporosis	7.76e-05	0.000161	CcSEcCtD
Tramadol—Nausea—Pamidronate—osteoporosis	7.66e-05	0.000158	CcSEcCtD
Tramadol—Dizziness—Conjugated Estrogens—osteoporosis	7.5e-05	0.000155	CcSEcCtD
Tramadol—Vomiting—Zoledronate—osteoporosis	7.49e-05	0.000155	CcSEcCtD
Tramadol—Feeling abnormal—Estradiol—osteoporosis	7.48e-05	0.000155	CcSEcCtD
Tramadol—Rash—Zoledronate—osteoporosis	7.43e-05	0.000154	CcSEcCtD
Tramadol—Gastrointestinal pain—Estradiol—osteoporosis	7.42e-05	0.000154	CcSEcCtD
Tramadol—Dermatitis—Zoledronate—osteoporosis	7.42e-05	0.000154	CcSEcCtD
Tramadol—Headache—Zoledronate—osteoporosis	7.38e-05	0.000153	CcSEcCtD
Tramadol—Vomiting—Conjugated Estrogens—osteoporosis	7.21e-05	0.000149	CcSEcCtD
Tramadol—Urticaria—Estradiol—osteoporosis	7.21e-05	0.000149	CcSEcCtD
Tramadol—Abdominal pain—Estradiol—osteoporosis	7.18e-05	0.000148	CcSEcCtD
Tramadol—Body temperature increased—Estradiol—osteoporosis	7.18e-05	0.000148	CcSEcCtD
Tramadol—Rash—Conjugated Estrogens—osteoporosis	7.15e-05	0.000148	CcSEcCtD
Tramadol—Dermatitis—Conjugated Estrogens—osteoporosis	7.15e-05	0.000148	CcSEcCtD
Tramadol—Headache—Conjugated Estrogens—osteoporosis	7.11e-05	0.000147	CcSEcCtD
Tramadol—Nausea—Zoledronate—osteoporosis	7e-05	0.000145	CcSEcCtD
Tramadol—Nausea—Conjugated Estrogens—osteoporosis	6.74e-05	0.000139	CcSEcCtD
Tramadol—Hypersensitivity—Estradiol—osteoporosis	6.69e-05	0.000138	CcSEcCtD
Tramadol—Asthenia—Estradiol—osteoporosis	6.51e-05	0.000135	CcSEcCtD
Tramadol—Pruritus—Estradiol—osteoporosis	6.42e-05	0.000133	CcSEcCtD
Tramadol—Diarrhoea—Estradiol—osteoporosis	6.21e-05	0.000128	CcSEcCtD
Tramadol—Dizziness—Estradiol—osteoporosis	6e-05	0.000124	CcSEcCtD
Tramadol—Vomiting—Estradiol—osteoporosis	5.77e-05	0.000119	CcSEcCtD
Tramadol—Rash—Estradiol—osteoporosis	5.73e-05	0.000118	CcSEcCtD
Tramadol—Dermatitis—Estradiol—osteoporosis	5.72e-05	0.000118	CcSEcCtD
Tramadol—Headache—Estradiol—osteoporosis	5.69e-05	0.000118	CcSEcCtD
Tramadol—Nausea—Estradiol—osteoporosis	5.39e-05	0.000112	CcSEcCtD
Tramadol—CYP2D6—Biological oxidations—POMC—osteoporosis	2.95e-05	0.000907	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CALCA—osteoporosis	2.92e-05	0.000897	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAP1A—osteoporosis	2.91e-05	0.000894	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CNR2—osteoporosis	2.89e-05	0.000886	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MGLL—osteoporosis	2.88e-05	0.000884	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—WNT1—osteoporosis	2.87e-05	0.000881	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	2.87e-05	0.00088	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	2.86e-05	0.000878	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—IDH2—osteoporosis	2.85e-05	0.000874	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFATC1—osteoporosis	2.84e-05	0.000872	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DKK1—osteoporosis	2.82e-05	0.000865	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MGLL—osteoporosis	2.8e-05	0.000859	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTHLH—osteoporosis	2.8e-05	0.000859	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BMP2—osteoporosis	2.8e-05	0.000859	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PKM—osteoporosis	2.79e-05	0.000855	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—FDPS—osteoporosis	2.79e-05	0.000855	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—FGB—osteoporosis	2.74e-05	0.000841	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LRP5—osteoporosis	2.73e-05	0.000839	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—WNT1—osteoporosis	2.71e-05	0.000833	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—POMC—osteoporosis	2.71e-05	0.000831	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP27A1—osteoporosis	2.68e-05	0.000821	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CALCA—osteoporosis	2.66e-05	0.000815	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PSMA2—osteoporosis	2.64e-05	0.000812	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PSMA5—osteoporosis	2.64e-05	0.000812	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PGLS—osteoporosis	2.64e-05	0.000811	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPD2—osteoporosis	2.64e-05	0.000811	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGA—osteoporosis	2.64e-05	0.00081	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LRP6—osteoporosis	2.61e-05	0.000802	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ACP5—osteoporosis	2.6e-05	0.000799	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	2.6e-05	0.000799	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	2.6e-05	0.000797	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—P4HB—osteoporosis	2.57e-05	0.00079	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TLN1—osteoporosis	2.56e-05	0.000787	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	2.52e-05	0.000773	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTH—osteoporosis	2.5e-05	0.000768	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CALCA—osteoporosis	2.46e-05	0.000756	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAP1A—osteoporosis	2.46e-05	0.000755	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BMP2—osteoporosis	2.46e-05	0.000753	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTHLH—osteoporosis	2.46e-05	0.000753	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—IDH2—osteoporosis	2.45e-05	0.000752	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CNR2—osteoporosis	2.44e-05	0.000749	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.42e-05	0.000743	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TPI1—osteoporosis	2.42e-05	0.000743	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PNP—osteoporosis	2.42e-05	0.000741	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ATIC—osteoporosis	2.42e-05	0.000741	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—POMC—osteoporosis	2.4e-05	0.000738	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGB—osteoporosis	2.4e-05	0.000737	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFATC1—osteoporosis	2.4e-05	0.000737	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DKK1—osteoporosis	2.38e-05	0.000731	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—POMC—osteoporosis	2.33e-05	0.000715	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PSMA2—osteoporosis	2.32e-05	0.000712	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PSMA5—osteoporosis	2.32e-05	0.000712	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.3e-05	0.000707	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—WNT1—osteoporosis	2.29e-05	0.000704	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CALCA—osteoporosis	2.29e-05	0.000702	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—P4HB—osteoporosis	2.28e-05	0.000698	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ACP5—osteoporosis	2.24e-05	0.000687	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KL—osteoporosis	2.24e-05	0.000687	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GAPDH—osteoporosis	2.23e-05	0.000686	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGA—osteoporosis	2.23e-05	0.000685	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—P4HB—osteoporosis	2.21e-05	0.000678	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TLN1—osteoporosis	2.21e-05	0.000677	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	2.2e-05	0.000675	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—POMC—osteoporosis	2.18e-05	0.00067	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RAP1A—osteoporosis	2.18e-05	0.000668	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CALCA—osteoporosis	2.16e-05	0.000663	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTH—osteoporosis	2.15e-05	0.00066	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6R—osteoporosis	2.13e-05	0.000654	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAP1A—osteoporosis	2.11e-05	0.000648	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—POMC—osteoporosis	2.11e-05	0.000647	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CNR2—osteoporosis	2.1e-05	0.000643	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.09e-05	0.00064	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TPI1—osteoporosis	2.08e-05	0.000639	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	2.08e-05	0.000638	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTHLH—osteoporosis	2.07e-05	0.000637	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BMP2—osteoporosis	2.07e-05	0.000637	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFATC1—osteoporosis	2.06e-05	0.000633	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CA2—osteoporosis	2.05e-05	0.00063	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—OXCT1—osteoporosis	2.05e-05	0.00063	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DKK1—osteoporosis	2.05e-05	0.000628	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGB—osteoporosis	2.03e-05	0.000623	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MGLL—osteoporosis	2e-05	0.000614	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—WNT1—osteoporosis	1.97e-05	0.000605	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KL—osteoporosis	1.96e-05	0.000602	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PSMA2—osteoporosis	1.96e-05	0.000602	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PSMA5—osteoporosis	1.96e-05	0.000602	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—P4HB—osteoporosis	1.96e-05	0.000601	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—POMC—osteoporosis	1.93e-05	0.000593	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GAPDH—osteoporosis	1.92e-05	0.00059	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGA—osteoporosis	1.92e-05	0.000588	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.91e-05	0.000587	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—P4HB—osteoporosis	1.9e-05	0.000584	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	1.89e-05	0.00058	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RAP1A—osteoporosis	1.87e-05	0.000574	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.87e-05	0.000573	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTH—osteoporosis	1.85e-05	0.000568	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.83e-05	0.000561	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PKM—osteoporosis	1.82e-05	0.000559	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—FDPS—osteoporosis	1.82e-05	0.000559	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAP1A—osteoporosis	1.82e-05	0.000558	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CNR2—osteoporosis	1.8e-05	0.000554	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.8e-05	0.000551	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	1.79e-05	0.00055	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTHLH—osteoporosis	1.78e-05	0.000547	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BMP2—osteoporosis	1.78e-05	0.000547	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.78e-05	0.000547	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFATC1—osteoporosis	1.77e-05	0.000545	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DKK1—osteoporosis	1.76e-05	0.00054	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO1—osteoporosis	1.76e-05	0.00054	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.75e-05	0.000538	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGB—osteoporosis	1.74e-05	0.000535	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PSMA2—osteoporosis	1.73e-05	0.000532	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PSMA5—osteoporosis	1.73e-05	0.000532	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPD2—osteoporosis	1.73e-05	0.00053	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PGLS—osteoporosis	1.73e-05	0.00053	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—IDH2—osteoporosis	1.7e-05	0.000522	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—WNT1—osteoporosis	1.7e-05	0.000521	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.7e-05	0.000521	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PSMA5—osteoporosis	1.68e-05	0.000517	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PSMA2—osteoporosis	1.68e-05	0.000517	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KL—osteoporosis	1.66e-05	0.000509	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGA—osteoporosis	1.65e-05	0.000506	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	1.63e-05	0.000499	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.62e-05	0.000496	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.6e-05	0.000491	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PNP—osteoporosis	1.58e-05	0.000485	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ATIC—osteoporosis	1.58e-05	0.000485	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.58e-05	0.000484	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALCA—osteoporosis	1.57e-05	0.000481	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ACP5—osteoporosis	1.56e-05	0.000478	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ADCY5—osteoporosis	1.54e-05	0.000472	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTHLH—osteoporosis	1.53e-05	0.000471	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IRS2—osteoporosis	1.53e-05	0.000471	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BMP2—osteoporosis	1.53e-05	0.000471	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—POMC—osteoporosis	1.53e-05	0.000469	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO1—osteoporosis	1.51e-05	0.000464	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—LEP—osteoporosis	1.5e-05	0.000461	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGB—osteoporosis	1.5e-05	0.000461	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000458	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000458	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SPP1—osteoporosis	1.49e-05	0.000456	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSMA2—osteoporosis	1.45e-05	0.000445	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSMA5—osteoporosis	1.45e-05	0.000445	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TPI1—osteoporosis	1.45e-05	0.000444	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ESR1—osteoporosis	1.43e-05	0.00044	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KL—osteoporosis	1.42e-05	0.000437	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP19A1—osteoporosis	1.41e-05	0.000432	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.39e-05	0.000426	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—P4HB—osteoporosis	1.36e-05	0.000418	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.36e-05	0.000416	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALCA—osteoporosis	1.35e-05	0.000414	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IRS2—osteoporosis	1.35e-05	0.000413	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—OXCT1—osteoporosis	1.34e-05	0.000412	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CA2—osteoporosis	1.34e-05	0.000412	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IRS1—osteoporosis	1.34e-05	0.000411	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GAPDH—osteoporosis	1.34e-05	0.00041	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—osteoporosis	1.32e-05	0.000404	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—LEP—osteoporosis	1.32e-05	0.000404	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MGLL—osteoporosis	1.31e-05	0.000402	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RAP1A—osteoporosis	1.3e-05	0.000399	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.3e-05	0.000399	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—osteoporosis	1.29e-05	0.000396	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6R—osteoporosis	1.26e-05	0.000386	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SPP1—osteoporosis	1.26e-05	0.000386	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ESR1—osteoporosis	1.26e-05	0.000386	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF1—osteoporosis	1.24e-05	0.000381	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000376	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000371	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000367	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IRS1—osteoporosis	1.17e-05	0.00036	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000358	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ADCY5—osteoporosis	1.15e-05	0.000353	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX1—osteoporosis	1.14e-05	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.14e-05	0.000349	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—osteoporosis	1.13e-05	0.000347	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000342	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—IDH2—osteoporosis	1.11e-05	0.000342	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—LEP—osteoporosis	1.11e-05	0.000341	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6R—osteoporosis	1.1e-05	0.000339	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.09e-05	0.000334	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.000331	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.06e-05	0.000326	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—osteoporosis	1.06e-05	0.000324	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO1—osteoporosis	1.05e-05	0.000323	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.05e-05	0.000321	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000318	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000318	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ACP5—osteoporosis	1.02e-05	0.000312	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS1—osteoporosis	9.92e-06	0.000305	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ADCY5—osteoporosis	9.88e-06	0.000303	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—osteoporosis	9.85e-06	0.000302	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS2—osteoporosis	9.76e-06	0.0003	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADCY5—osteoporosis	9.61e-06	0.000295	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—osteoporosis	9.56e-06	0.000293	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LEP—osteoporosis	9.55e-06	0.000293	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—osteoporosis	9.49e-06	0.000291	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TPI1—osteoporosis	9.46e-06	0.00029	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6R—osteoporosis	9.32e-06	0.000286	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—osteoporosis	9.29e-06	0.000285	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—osteoporosis	9.19e-06	0.000282	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ESR1—osteoporosis	9.12e-06	0.00028	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—osteoporosis	9.09e-06	0.000279	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—P4HB—osteoporosis	8.9e-06	0.000273	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GAPDH—osteoporosis	8.73e-06	0.000268	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS1—osteoporosis	8.52e-06	0.000262	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RAP1A—osteoporosis	8.51e-06	0.000261	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—osteoporosis	8.45e-06	0.000259	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.41e-06	0.000258	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS2—osteoporosis	8.41e-06	0.000258	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—osteoporosis	8.32e-06	0.000255	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—osteoporosis	8.23e-06	0.000252	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—osteoporosis	8.21e-06	0.000252	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6R—osteoporosis	8.01e-06	0.000246	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.89e-06	0.000242	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—osteoporosis	7.85e-06	0.000241	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—osteoporosis	7.45e-06	0.000229	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—osteoporosis	7.44e-06	0.000228	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS1—osteoporosis	7.34e-06	0.000225	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—osteoporosis	7.27e-06	0.000223	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—osteoporosis	7.07e-06	0.000217	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—osteoporosis	7.03e-06	0.000216	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6R—osteoporosis	6.89e-06	0.000212	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO1—osteoporosis	6.88e-06	0.000211	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADCY5—osteoporosis	6.87e-06	0.000211	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—osteoporosis	6.85e-06	0.00021	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—osteoporosis	6.8e-06	0.000209	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMA5—osteoporosis	6.78e-06	0.000208	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMA2—osteoporosis	6.78e-06	0.000208	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—osteoporosis	6.54e-06	0.000201	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—osteoporosis	6.52e-06	0.0002	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—osteoporosis	6.32e-06	0.000194	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—osteoporosis	6.04e-06	0.000185	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—osteoporosis	5.6e-06	0.000172	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—osteoporosis	5.52e-06	0.00017	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—osteoporosis	5.51e-06	0.000169	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.5e-06	0.000169	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—osteoporosis	5.2e-06	0.00016	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—osteoporosis	5.05e-06	0.000155	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—osteoporosis	4.91e-06	0.000151	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—osteoporosis	4.74e-06	0.000146	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.73e-06	0.000145	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADCY5—osteoporosis	4.49e-06	0.000138	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—osteoporosis	4.48e-06	0.000137	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—osteoporosis	4.15e-06	0.000127	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—osteoporosis	4.13e-06	0.000127	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—osteoporosis	4.08e-06	0.000125	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—osteoporosis	4.07e-06	0.000125	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—osteoporosis	3.57e-06	0.000109	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—osteoporosis	3.3e-06	0.000101	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—osteoporosis	3.07e-06	9.42e-05	CbGpPWpGaD
